BioNotebook: Offerings slow on market woes, others raise venture cash
It was a difficult week for biotechnology fundraising, at least in the public markets, given the shaky ongoing dialog about the state of the biotech stock investing.
It was a difficult week for biotechnology fundraising, at least in the public markets, given the shaky ongoing dialog about the state of the biotech stock investing.